← FDA DRUG APPROVALS

FDA ANDA · ANDA213057

ISOSORBIDE DINITRATE

Sponsor: ZYDUS LIFESCIENCES

APPLICATION
ANDA213057
TYPE
ANDA
ORIGINAL APPROVAL
2019-11-20
LATEST ACTION
2019-11-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ISOSORBIDE DINITRATEPrescription
ISOSORBIDE DINITRATE 40MG · TABLET · ORAL
ISOSORBIDE DINITRATEPrescription
ISOSORBIDE DINITRATE 20MG · TABLET · ORAL
ISOSORBIDE DINITRATEPrescription
ISOSORBIDE DINITRATE 5MG · TABLET · ORAL
ISOSORBIDE DINITRATEPrescription
ISOSORBIDE DINITRATE 30MG · TABLET · ORAL
ISOSORBIDE DINITRATEPrescription
ISOSORBIDE DINITRATE 10MG · TABLET · ORAL

Approval history

2019-11-20UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →